|
|
|
Insider
Information: |
Crystal Adam |
Relationship: |
|
City: |
Watertown |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
139,575 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
139,575 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
C4 Therapeutics, Inc. |
CCCC |
Chief Medical Officer |
2023-01-30 |
20,097 |
2021-07-01 |
0 |
Premium* |
|
Tango Therapeutics Ord Shs |
TNGX |
|
2024-02-07 |
119,478 |
2023-03-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TNGX |
Tango Therapeutics Ord Sh... |
See Remarks |
|
2024-02-07 |
4 |
S |
$12.62 |
$51,527 |
D/D |
(4,083) |
119,478 |
0 |
- |
|
TNGX |
Tango Therapeutics Ord Sh... |
See Remarks |
|
2024-02-06 |
4 |
S |
$12.56 |
$53,868 |
D/D |
(4,288) |
123,561 |
0 |
- |
|
TNGX |
Tango Therapeutics Ord Sh... |
See Remarks |
|
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
46,599 |
46,599 |
0 |
- |
|
TNGX |
Tango Therapeutics Ord Sh... |
See Remarks |
|
2023-11-01 |
4 |
S |
$8.39 |
$62,994 |
D/D |
(7,507) |
81,250 |
0 |
- |
|
TNGX |
Tango Therapeutics Ord Sh... |
See Remarks |
|
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
81,250 |
81,250 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2023-01-30 |
4 |
D |
$7.78 |
$10,122 |
D/D |
(1,301) |
20,097 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
21,398 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
18,750 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2022-01-04 |
4 |
AS |
$31.59 |
$474,968 |
D/D |
(15,000) |
15,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2022-01-04 |
4 |
OE |
$6.49 |
$97,350 |
D/D |
15,000 |
30,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-12-22 |
4 |
OE |
$6.49 |
$32,450 |
D/D |
5,000 |
15,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-10-08 |
4 |
OE |
$6.49 |
$64,900 |
D/D |
10,000 |
10,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-10-01 |
4 |
AS |
$44.25 |
$681,438 |
D/D |
(15,000) |
0 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-10-01 |
4 |
OE |
$4.98 |
$74,700 |
D/D |
15,000 |
15,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-07-29 |
4 |
AS |
$45.00 |
$675,000 |
D/D |
(15,000) |
0 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-07-29 |
4 |
OE |
$4.98 |
$74,700 |
D/D |
15,000 |
15,000 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-07-01 |
4 |
AS |
$37.93 |
$569,666 |
D/D |
(15,000) |
0 |
0 |
- |
|
CCCC |
C4 Therapeutics, Inc. |
Chief Medical Officer |
|
2021-07-01 |
4 |
OE |
$6.50 |
$97,500 |
D/D |
15,000 |
15,000 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|